APA

Fontanges T., Beorchia S., Douvin C., Delassalle P., Combis J., Hanslik B., Jacques J., Filoche B., Desmorat H., Chandelier C. & Ouzan D. (20071227). Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. : Gastroenterologie clinique et biologique.

Chicago

Fontanges Thierry, Beorchia Sylvain, Douvin Catherine, Delassalle Patrick, Combis Jean-Marc, Hanslik Bertrand, Jacques Jean-Paul, Filoche Bernard, Desmorat Hervé, Chandelier Catherine and Ouzan Denis. 20071227. Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. : Gastroenterologie clinique et biologique.

Harvard

Fontanges T., Beorchia S., Douvin C., Delassalle P., Combis J., Hanslik B., Jacques J., Filoche B., Desmorat H., Chandelier C. and Ouzan D. (20071227). Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. : Gastroenterologie clinique et biologique.

MLA

Fontanges Thierry, Beorchia Sylvain, Douvin Catherine, Delassalle Patrick, Combis Jean-Marc, Hanslik Bertrand, Jacques Jean-Paul, Filoche Bernard, Desmorat Hervé, Chandelier Catherine and Ouzan Denis. Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection. : Gastroenterologie clinique et biologique. 20071227.